Apte receives Camras Award

Rajendra S. Apte, MD, PhD, the Paul A. Cibis Distinguished Professor of Ophthalmology & Visual Sciences, is one of three recipients of the 2014 Pfizer Ophthalmics Carl Camras Translational Research Award.

Becker memorial set for Nov. 22

Friends and family of Bernard Becker, MD, will gather for a memorial Friday, Nov. 22. Becker, professor emeritus of ophthalmology and visual sciences, died at his home Aug. 28, 2013, at the age of 93.

Recycling in the eye promotes good vision

Researchers have found that seeing well as we age depends, at least in part, on a recycling process in the eye that mops up cellular debris and recycles light-sensitive proteins. The findings suggest that disruptions in that process may harm vision and play a key role in the development of eye diseases related to aging. Inside the retinal pigment epithelium cells pictured are structures used for recycling (green) that engulf and digest spent parts of photoreceptor cells (red).

Doctor wins NIH prize for ideas to restore vision

A Washington University retina specialist is one of 10 U.S. scientists selected by the National Eye Institute for an innovative project to improve or restore vision. The winning proposal from vitreoretinal surgery fellow Rajesh C. Rao, MD, was chosen from nearly 500 entries. Rao was the youngest winner in the national competition.

Apte new Cibis Professor of Ophthalmology

Rajendra S. Apte, MD, PhD, is the new Paul A. Cibis Distinguished Professor of Ophthalmology and Visual Sciences at Washington University School of Medicine in St. Louis. The second faculty member to hold the Cibis chair, Apte focuses his research on inflammation and aberrant blood vessel growth that together wreak havoc in eye diseases, such as age-related macular degeneration, the leading cause of blindness in older Americans.

Genetic test identifies eye cancer tumors likely to spread

Researchers at Washington University School of Medicine in St. Louis have developed a genetic test that can accurately predict whether the most common form of eye cancer will spread to other parts of the body, particularly the liver. The test successfully classified tumors more than 97 percent of the time.

A closer look at Becker’s special collection

In one way or another, nearly everyone at Washington University School of Medicine has heard of Bernard Becker, MD. Many use the beautiful Bernard Becker Medical Library or consult rare eye books there from the well-known Becker collection. In the Department of Ophthalmology, which Becker chaired for more than 35 years, faculty members know well his landmark research on glaucoma.

Drug may slow spread of deadly eye cancer

A drug commonly used to treat seizures appears to make eye tumors less likely to grow if they spread to other parts of the body, according to new research at the School of Medicine. Their findings are available online in the journal Clinical Cancer Research.
View More Stories